Colorectal Cancer Alliance Appoints New Board Members from Goldman Sachs, McKinsey, and Latham Watkins to Bolster Research Initiatives
The Colorectal Cancer Alliance has announced the appointment of four new members to its Board of Directors. These new directors bring a wealth of experience from various sectors, including healthcare investment banking, biotechnology, life sciences, law, public policy, and oncology. The appointees are Ross Cohen, a Managing Director in Goldman Sachs’ Healthcare Investment Banking Group; Lenny Mendonça, Senior Partner Emeritus of McKinsey & Company; Cory Tull, a corporate partner and Deputy Office Managing Partner at Latham & Watkins; and Peter Wright, a partner in McKinsey’s Life Sciences practice. The organization aims to leverage their diverse expertise to accelerate colorectal cancer research and treatment initiatives, including Project Cure CRC and the development of an adaptive clinical trial platform. Several new board members have personal connections to colorectal cancer, adding a direct perspective to the organization's mission.
